ストックスクリーナーアプリを入手
1.68
8.39%
0.13
前日終値:
$1.55
開ける：
$1.55
24時間の取引高:
107.47K
Relative Volume:
2.05
時価総額：
$942.08M
収益：
当期純損益:
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
1週間 パフォーマンス:
+10.53%
1か月 パフォーマンス:
-12.04%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$1.53
$1.75
1週間の範囲:
$1.47
$1.62
52週間の値動き範囲:
$1.42
$14.50
Sl Science Holding Ltd Stock (SLBT) Company Profile
Compare SLBT vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLBT
Sl Science Holding Ltd
|
1.68 | 942.08M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
509.80 | 129.21B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
237.94 | 94.99B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
801.89 | 82.56B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
849.51 | 53.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
371.87 | 42.07B | 5.76B | 514.49M | 1.10B | 4.4813 |
Sl Science Holding Ltd (SLBT) 最新ニュース
The CEO buys 4.55M ordinary shares in SL Science Holding (SLBT). - Stock Titan
A CEO buys shares without changing his total ownership in SL Science Holding (SLBT). - Stock Titan
SLBT Price Today: SL Science Holding Limited Stock Price, Quote & Chart | MEXC - MEXC
Business council charts new SL–Canada trade drive - Island.lk
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD - Investing.com Canada
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD By Investing.com - Investing.com South Africa
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD - investing.com
September 2026 Nasdaq Stock Market Bell Ceremonies - Nasdaq
Morning Market Movers: RARE, BIAF, TLYS, SNOW See Big Swings - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
NetApp, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session - Benzinga
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company - The Manila Times
SL Science Rings Nasdaq Bell, Marks First Quarter as Public Company and Advances γδ T Cell Therapy Platform - Quiver Quantitative
SL Science Rings Nasdaq Bell, Marks First Quarter as Public Company and Advances γδ T Cell Therapy Platform - Quiver Quantitative
SL Science Holding Discloses Resignation of Vice President of Finance - theglobeandmail.com
Johnson Lau Steps Down as VP of Finance at SL Science Holding Ltd - Kalkine Media
SL Science Holding Discloses Resignation of Vice President of Finance - TipRanks
SL Science (SLBT) finance VP steps down with no insider trades - Stock Titan
SL Science (SLBT) finance VP to step down Aug. 31 - Stock Titan
SL Science licensor files exosome drug master file with FDA - Investing.com India
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform - manilatimes.net
A new FDA filing covers exosomes; studies indicate they can cross the blood-brain barrier - Stock Titan
SL Science licensor files exosome drug master file with FDA - investing.com
SL Science Holding Ltd Switches Audit Firm to TAAD LLP in Late August 2026 - TipRanks
SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall - Yahoo Finance
SL Science Holding Limited Ordinary Shares (NASDAQ: SLBT) Stock Price, News & Analysis - kalkine.com.au
SL Science Holding Limited Ordinary Shares (NASDAQ: SLBT) Stock Price, News & Analysis - kalkine.ca
SL Science Holding Ltd SEC Filing (Aug 13, 2026) - Stock Titan
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
RBGLY Stock Price and Chart — OTC:RBGLY - TradingView
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma - The Manila Times
SL Science Holding Limited Announces Publication of Peer-Reviewed Framework for γδ T Cell Therapy in Glioblastoma - Quiver Quantitative
Brain Cancer Cell Therapy Trials Must Track Cells, Review Says - Stock Titan
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
AbCellera Stock Soars 30% After Menopause Drug ABCL635 Hits Phase 2 Success In Hot Flash Trial Results - International Business Times Australia
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK
Operating expenses (excl. COGS) of SL Science Holding Limited – NASDAQ:SLBT - TradingView
SL Science Holding Ord Shs (SLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
SL Science Holding (NASDAQ: SLBT) files to register resale of 1.04M shares - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Saol Therapeutics Announces the Acceptance of Resubmission of SL1009 (DCA) by the FDA with PDUFA Date of Dec. 30, 2026 - Yahoo Finance
SL Science Holding Ord Shs (SLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SLBT|SL Science Holding Ord Shs|Price:3.200|Chg%:+0.555 - TradingKey
SL Science Holding Ord Shs (SLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SL Science Holding Ord Shs (SLBT) Cash Flow - TradingKey
SL Science Holding Ord Shs (SLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sl Science Holding Ltd (SLBT) 財務データ
Sl Science Holding Ltd (SLBT) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
3.77%
10.88%
大文字化:
|
ボリューム (24 時間):